Clinical Trials on 乙型肝炎 in Hong Kong
总计308个结果
-
Hoffmann-La Roche完全的
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Gilead SciencesF-star Therapeutics, Inc.终止
-
Hoffmann-La Roche终止
-
Humanity and Health Research CentreEmory University; Beijing 302 Hospital完全的
-
Assembly Biosciences完全的
-
NovartisNovartis Pharmaceuticals完全的
-
Enyo Pharma完全的
-
Chinese University of Hong KongHenan Provincial People's Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Samsung Medical Center完全的弥漫性大 B 细胞淋巴瘤或滤泡性淋巴瘤患者 | 接受 Rituximab-CHOP 或 Rituximab-CVP 治疗的患者大韩民国, 马来西亚, 新加坡, 中国
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University招聘中
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Sanwa BioTech LimitedChinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong尚未招聘
-
Brii Biosciences LimitedVir Biotechnology, Inc.主动,不招人
-
Alnylam Pharmaceuticals终止乙型肝炎 | 慢性乙型肝炎 | 乙型肝炎,慢性 | 乙肝病毒 | 乙型肝炎感染英国, 新西兰, 新加坡, 大韩民国, 澳大利亚, 香港
-
Novartis PharmaceuticalsHuman Genome Sciences Inc.终止
-
Enyo PharmaParexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins终止
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology Group未知B细胞非霍奇金淋巴瘤 | 成熟 B 细胞白血病 Burkitt 型比利时, 法国, 英国, 荷兰, 加拿大, 匈牙利, 意大利, 波兰, 西班牙, 中国
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals完全的
-
Novira Therapeutics, Inc.完全的
-
Hoffmann-La Roche招聘中
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University; Yamanashi Prefectural Central...招聘中
-
Aligos Therapeutics终止
-
Arrowhead Pharmaceuticals终止
-
GlaxoSmithKline完全的